#
Bunavail Buccal Film
  • Professionals
  • FDA PI

Bunavail Buccal Film

Generic name:buprenorphine and naloxone
Dosage form: buccal film
Drug class:Narcotic analgesic combinations

Medically reviewed by Drugs.com. Last updated on Mar 1, 2021.

Indications and Usage for Bunavail Buccal Film

BUNAVAIL is indicated for the treatment of opioid dependence. BUNAVAIL should be used as part of a complete treatment plan that includes counseling and psychosocial support.

Bunavail Buccal Film Dosage and Administration

Drug Addiction Treatment Act

Under the Drug Addiction Treatment Act (DATA) codified at 21 U.S.C. 823(g), prescription use of this product in the treatment of opioid dependence is limited to healthcare providers who meet certain qualifying requirements, and who have notified the Secretary of Health and Human Services (HHS) of their intent to prescribe this product for the treatment of opioid dependence and have been assigned a unique identification number that must be included on every prescription.

Important Dosage and Administration Information

BUNAVAIL is administered buccally as a single daily dose. The difference in bioavailability of BUNAVAIL compared to SUBOXONE sublingual tablet requires a different dosage strength to be administered to the patient. A BUNAVAIL 4.2 mg/0.7 mg buccal film provides equivalent buprenorphine exposure to a SUBOXONE 8 mg/2 mg sublingual tablet.

Medication should be prescribed in consideration of the frequency of visits. Provision of multiple refills is not advised early in treatment or without appropriate patient follow-up visits.

Patient Access to Naloxone for the Emergency Treatment of Opioid Overdose...